BioLaurus

Your PreClinical Molecular Imaging Specialists - Imaging the Future of Therapeutics

WHY WORK WITH US?

We aren’t just partners, we are “Hybrid Integrators” – working direclty with you from beginning to end, involved in your internal processes as much (or as little) as you wish. You decide, and we bring you solutions.

READ MORE
MOLECULAR IMAGING SOLUTIONS

Our translational preclinical molecular imaging capabilities range from PET and SPECT to optical and luminescence imaging. With expertise in a plethora of therapeutic areas – we can provide your study needs.

READ MORE
RESOURCES & BLOG

Don’t need imaging? We can be a scientific resource – sharing information, networking, and posting some fun blogs along the way. Want to be interviewed for one of our articles? Just contact us – we would be happy to include you!

READ MORE

A few things we’re great at

At BioLaurus, we take pride in our expertise and specialization in the niche field of preclinical molecular imaging. And your needs are important to us – not just as a study, but as a scientific partner as well. We strive for excellence across all performance platforms – scientific, relational and budgetary. And we deliver.

MOLECULAR IMAGING

We are in-vivo preclinical molecular imaging specialists. From discovery stage efficacy studies to follow-on safety/tox studies for clinical stage drugs, we have a demonstrated ability to develop innovative studies and assays, harnessing the power of in-vivo quantitative imaging.

READ MORE
STUDY DESIGN SERVICES

We create a unique imaging strategy, research plan, and study design for your specific needs. We then implement in BioLaurus approved and AAALAC accredited vivariums, in parallel with detailed protocol writing, on site monitoring, BioLaurus in-life study technicians, final data analysis and report. ALL of this is performed while working closely with you – to drive your strategies and goals towards successful study outcomes. We become part of YOUR TEAM.

NON-HUMAN PRIMATE STUDIES

Need NHP? We can provide solutions using various primate species, conducted in registered facilities and in accordance with local and global animal care and treatment guidelines. Specialties include PK/PD and Safety Studies utilizing SPECT or gamma camera imaging, platelet and T-cell radiolabeling, and more.

READ MORE
ASSAY DEVELOPMENT

BioLaurus is a leader in the development of novel imaging assays and the adaptation of clinical imaging procedurs to the preclinical research space. Bringing the power of quantitative in-vivo and longitudinal means getting the question right first, then assembling the technologies which provide you data-rich imaging for your assay.

READ MORE
CASE STUDY

CT Imaging of EBC-1 Lung Metastasis

The evaluation of lung metastases in mouse models has long been challenging. Lung metastasis models such as the EBC-1 non-small cell lung carcinoma that grows along bronchi and blood vessels can be imaged by CT. In images shown here, normal and tumor bearing inflated lungs are imaged in situ at 30um resolution on a SCANCO Medical microCT-40

TECHNOLOGY

Micro-CT Imaging is a 3D solution, offering resolution to 10-30um.

MORPHOLOGY

Lung tissue characteristics create low x-ray attenuation of air – results in high contrast.

CASE STUDY – ASSAY DEVELOPMENT

Novel Enterocyte GI Contrast Agent

We developed a novel CT contrast agent to track in-vivo lipid absorption in the small intestine. This agent allows for real-time assessment of enterocyte function by visualizing the absorption and secretion of free fatty acides from triglycerides in the small intestines of rats.

TECHNOLOGY

Breakthrough technology could measure the rates of lipid absorption and secrtion in-vivo.

ASSAY DEVELOPMENT

BioLaurus is a leader in the development of novel imaging assays.

Client Testimonials

Don’t take our word for it – here’s what our clients say:

The BioLaurus “Can-Do” philosophy, flexibility, and agility with study design changes afforded the opportunity to conduct investigative studies that were not possible with other clinical research organizations.

Husam Younis, PharmD, PhD

Senior Director, Nonclinical Development

Dr Bourdon is a distinguished Bio-imaging expert with extensive experience and knowledge of imaging technologies. With great attention to detail, the study was only performed once, with all goals met – allowing for swift publication.

Jeff (Ssucheng) Hsu, PhD

Director, Immuno-Pharmacology

BioLaurus’ performance was outstanding in the study design and they provided trustworthy and insightful data and creative analysis techniques to get the most information from available data. I look forward to working with them in the future.

David Brewster
PhD, DABT

VP and Global Head – Drug Safety Evaluation

Join us! It will only take a minute

Latest Blogs

Check out our recent blogs about molecular imaging, preclinical studies, drug development – and plenty of other fun, related topics. If you have a suggestion for a blog (or would like to be interviewed), let us know!

Biolaurus’ New Website

You SPOKE, we LISTENED… We at BioLaurus our announcing our fresh, NEW WEBSITE – redesigned to better represent our Preclinical Molecular Imaging services we provide to YOU! Focusing on the “person to[…]

Read more

Cat got your tongue?

A BioLaurus Blog by Kimberly Brue If you don’t know where your keys, your car, or even your kids are at a certain time – you aren’t alone. Every day[…]

Read more

The Evolution of What?

Since the earth was born and man was created, there has been much evolution in the universe. Man, as a species, has evolved to what we are today (and we[…]

Read more

Contact us! We would love to chat.

CONTACT US